Kiviaq Overview
- Year Founded
-
2025
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$1.03M
- Investors
-
9
Kiviaq General Information
Description
Developer of integrated healthcare systems designed for medical accessibility and operational redesign. The company applies supply chain methodologies, integrating advanced technology, service standardization, and process optimization across clinical environments, enabling healthcare providers and institutions to restructure conventional workflows, improve service quality, and introduce scalable models that address both patient needs and systemic inefficiencies.
Contact Information
Website
www.kiviaq.comCorporate Office
- Noah Shiba Daimon 101
- 1-4-4 Shiba Daimon, Minato-ku
- Tokyo, Tokyo 105-0012
- Japan
Corporate Office
- Noah Shiba Daimon 101
- 1-4-4 Shiba Daimon, Minato-ku
- Tokyo, Tokyo 105-0012
- Japan
Kiviaq Timeline
Kiviaq Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC (Series A) | 14-Sep-2026 | $1.03M | Completed | Generating Revenue | ||
| 4. Accelerator/Incubator | 01-Oct-2025 | Completed | Generating Revenue | |||
| 3. Seed Round | 19-Aug-2025 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 06-Aug-2025 | $67.7K | $67.7K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 11-Jul-2025 | Completed | Generating Revenue |
Kiviaq Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| SS2 Preferred | ||||||||
| S2 Preferred | ||||||||
| S Class | 42,858 | $8.88 | $8.88 | 1x | $8.88 | 24.74% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Kiviaq Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Kiviaq Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Kiviaq Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Coral Capital. | Venture Capital | Minority | ||
| Mercuria Supply Chain Fund | Corporation | Minority | ||
| Spiral Capital (Tokyo) | Venture Capital | Minority | ||
| Creation Camp TENNOZ | Accelerator/Incubator | |||
| Call Doctor | VC-Backed Company | Minority |
Kiviaq FAQs
-
When was Kiviaq founded?
Kiviaq was founded in 2025.
-
Where is Kiviaq headquartered?
Kiviaq is headquartered in Tokyo, Japan.
-
What is the size of Kiviaq?
Kiviaq has 10 total employees.
-
What industry is Kiviaq in?
Kiviaq’s primary industry is Other Healthcare Technology Systems.
-
Is Kiviaq a private or public company?
Kiviaq is a Private company.
-
What is the current valuation of Kiviaq?
The current valuation of Kiviaq is .
-
What is Kiviaq’s current revenue?
The current revenue for Kiviaq is .
-
How much funding has Kiviaq raised over time?
Kiviaq has raised $1.5M.
-
Who are Kiviaq’s investors?
Coral Capital., Mercuria Supply Chain Fund, Spiral Capital (Tokyo), Creation Camp TENNOZ, and Call Doctor are 5 of 9 investors who have invested in Kiviaq.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
